A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial-Reference-Cited by-同舟云学术

A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial

Published:2015-11-16 Issue:6 Volume:57 Page:1406-1412
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Oh Sung Yong,Kim Won Seog,Kim Jin Seok,Chae Yee Soo,Lee Gyeong-Won,Eom Hyeon Seok,Ryoo Hun Mo,Lee Suee,Kim Seok Jin,Yoon Dok Hyun,Won Jong Ho,Hong Junshik,Park Jinny,Lee Sang-Min,Hong Jung Yong,Park Eunkyung,Kim Hyo Jung,Yang Deok-Hwan,Kim Hyo-Jin,Suh Cheolwon

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1099650

Reference30 articles.

1. Nongastric marginal zone B-cell lymphoma: Analysis of 247 cases

2. Marginal-zone lymphoma

3. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

4. Update on MALT lymphomas

5. WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy;International Journal of Molecular Sciences;2021-09-28

2. Marginal Zone Lymphomas;The Cancer Journal;2020-07

3. Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial;International Journal of Hematology;2018-01-22

4. Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy;British Journal of Haematology;2015-12-18